Cargando…
In situ delivery of biobutyrate by probiotic Escherichia coli for cancer therapy
Butyrate has a bioactive function to reduce carcinogenesis. To achieve targeted cancer therapy, this study developed bacterial cancer therapy (BCT) with butyrate as a payload. By metabolic engineering, Escherichia coli Nissle 1917 (EcN) was reprogrammed to synthesize butyrate (referred to as biobuty...
Autores principales: | Chiang, Chung-Jen, Hong, Yan-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438071/ https://www.ncbi.nlm.nih.gov/pubmed/34518590 http://dx.doi.org/10.1038/s41598-021-97457-3 |
Ejemplares similares
-
Metabolic engineering of probiotic Escherichia coli for cytolytic therapy of tumors
por: Chiang, Chung-Jen, et al.
Publicado: (2021) -
Enumeration of Escherichia coli in Probiotic Products
por: Zimmer, Camille, et al.
Publicado: (2019) -
Probiotic Escherichia coli inhibits biofilm formation of pathogenic E. coli via extracellular activity of DegP
por: Fang, Kuili, et al.
Publicado: (2018) -
Probiotic Properties of Escherichia coli Nissle in Human Intestinal Organoids
por: Pradhan, Suman, et al.
Publicado: (2020) -
Probiotic Escherichia coli Ameliorates Antibiotic-Associated Anxiety Responses in Mice
por: Park, Kiwoong, et al.
Publicado: (2021)